Subthalamic deep brain stimulation for resolving visuo-vestibular conflict in parkinson's disease

Active Grant Awarded

Award ID
R01NS143992
Recipient
Awarding agency
Obligated
$330,000

Award facts

Completion date 6% complete
Place of performance
Cleveland, OH 44106, USA

Award details come from USAspending.gov.

About this award

The Department of Health and Human Services, National Institutes of Health, National Institute of Neurological Disorders and Stroke awarded $330,000 to The Cleveland VA Medical Research & Education Foundation on August 7, 2026, under Grant R01NS143992. The award falls under Assistance Listing 93.853, Extramural Research Programs in the Neurosciences and Neurological Disorders, and funds research to optimize subthalamic nucleus deep brain stimulation (STN DBS) for self-motion perception and visuo-spatial navigation in Parkinson's disease while preserving its effect on motor symptoms.

Aim 1 examines how the location of tissue activation within the STN affects heading perception during visuo-vestibular conflict. The recipient will use a motion simulator and virtual reality to present synchronized or conflicting visual and vestibular signals, switch DBS on and off from different electrode contacts, and create a stimulation atlas identifying STN locations linked to changes in heading perception. Aim 2 identifies axonal pathways modulated by STN DBS. Methods include psychophysics, virtual reality, motion analysis, neuroimaging, and computational modeling, with clinical assessments of Functional Gait Assessment, Gait Disorientation Task, gait speed, and UPDRS-III.

The period of performance runs from August 7, 2026 through July 31, 2031. Place of performance is Cleveland, Ohio 44106.

Description

Abstract
Parkinson's disease (PD) affects about 10 million people globally, including 1 million americans. Beyond motor symptoms like tremors and rigidity, PD patients often struggle with visuo-spatial navigation, impacting skills such as pathfinding, spatial memory, and awareness, and affecting gait due to difficulties in resolving visuo-vestibular conflicts. These deficits are often unresponsive to conventional pharmacotherapy, making deep brain stimulation (DBS) surgery necessary. Subthalamic nucleus (STN) DBS is preferred for motor symptoms, but its impact on non-motor symptoms like spatial navigation varies. Our research aims to optimize STN DBS to enhance self- motion perception and visuo-spatial navigation in PD while maintaining its effectiveness on motor symptoms. We will investigate visuo-vestibular interactions and how STN DBS improves perception during visual-vestibular conflicts using psychophysics, virtual reality, motion analysis, neuroimaging, and computational modeling. Clinical assessments will include functional gait assessment (FGA), gait disorientation task (GDT), gait speed, and motor symptoms (UPDRS-III). We hypothesize that STN DBS improves heading perception during visual- vestibular conflict, with favorable effects linked to specific STN regions and pathways. Aim 1 will examine how the location of tissue activation within the STN affects heading perception during visuo-vestibular conflict. We will use a motion simulator and virtual reality to study heading perception under synchronized or conflicted visual and vestibular signals, combined with clinical assessments. We will also test the effects of STN DBS by switching DBS on and off from different electrode contacts and create a stimulation atlas to identify STN locations linked to changes in heading perception. Aim 2 will identify which axonal pathways modulated by STN DBS correlate with changes in heading perception during visuo-vestibular interaction. We will combine patient-specific vtas with tractography to pinpoint white-matter pathways that correlate with changes in heading perception. We hypothesize that hyperdirect pathway stimulation will improve heading perception, while cerebello-thalamic pathway stimulation will worsen IT. This research aims to improve treatment for navigational and balance impairments in PD, enhancing clinical outcomes and deepening our understanding of the role of basal ganglia in motion perception.

Quick answers

Who received award R01NS143992?

R01NS143992 was awarded to The Cleveland VA Medical Research & Education Foundation by National Institute of Neurological Disorders and Stroke (National Institutes of Health) on August 7, 2026.

How much is award R01NS143992 worth?

$330,000 has been obligated on R01NS143992.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award